Counteract project
Join the Frontline of Medical Research: Enrol in a Phase 1 Trial
About the Study:
We’re conducting a Phase 1 clinical trial to evaluate the safety of a new investigational drug, designed to protect both civilians and military personnel from biological threats. Your participation could help advance vital research that safeguards communities worldwide.
What's involved?
- Inhale the experimental product or placebo via face mask (up to 30 min, 4x/day)
- 5 days of dosing in our clinic, including 1 overnight stay
- Follow-up clinic visit (24–48 hrs after final dose)
- Phone check-in (2 weeks later)
- Health monitoring: exams, blood/urine tests, lung function, ECG
- Compensation will be provided for your time and inconvenience
- Your participation is completely voluntary
Who is eligible?
- Healthy adults (18–55), BMI 18.5–29.9
- Available for all visits
- Not pregnant/breastfeeding
- No recent clinical trial or blood donation
- No major medical issues or drug allergies
- Not on medications
- Understand spoken and written English
Interested?
For more information please contact: Professor Melissa McDonnell, Principal Investigator
counteract@universityofgalway.ie
Funded by the European Defence Fund
Version 2.0
Effective Date: 20/01/2026